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FAKTOR BERKAITAN DENGAN TAHAP HIPERTENSI DALAM KALANGAN 
DEWASA DI MALAYSIA MENGUNAKAN DATA SEKUNDER DARI 
TINJAUAN KESIHATAN DAN MORBIDITI KEBANGSAAN 2015 
 
ABSTRAK 
 
Pengenalan: Tekanan darah tinggi adalah masalah klasik dunia dan kekal sebagai beban 
kesihatan global yang utama. Sama ada secara tunggal atau bergabung dengan penyakit 
metabolik lain,tekanan darah tinggi meningkatkan risiko penyakit kardiovaskular. 
Penyakit ini bertanggungjawab kepada 7.4 juta kematian disebabkan oleh penyakit 
jantung koronari dan 6.7 juta kematian disebabkan strok.  
Objektif: Objektif kajian ini adalah untuk mengenalpasti prevalens dan faktor yang 
berkaitan dengan tahap hipertensi dalam  kalangan orang dewasa di Malaysia.  
Metodologi: Analisis data sekunder dari tinjauan keratan rentas menggunakan 
persampelan kluster berbilang lapisan berstrata dari Tinjaun Kesihatan dan Morbiditi 
Nasional 2015. Faktor demografi , parameter klinikal, ciri-ciri tingkah laku dan faktor 
risiko komorbiditi telah tersedia untuk analisis. Purata bacaan tekanan darah 
dikategorikan kepada empat kumpulan mengikut Laporan The 7th Report of Joint 
Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure 
(JNC7)  ialah Normal, pra-hipertensi, hipertensi tahap 1 dan hipertensi tahap 2.Regresi 
Logistik Ordinal Sampel Kompleks digunakan untuk analisis. 
 Keputusan: Sejumlah 15,738 orang dewasa telah dianalisis ini dengan purata  umur 
41.10 tahun (15.6 tahun). Prevalens pra hipertensi, hipertensi tahap 1 dan hipertensi tahap 
 xvi 
 
2 adalah masing-masing 45.8% (95% SK: 44.66, 47.97), 15.1% (95% SK: 14.34, 15.92) 
dan 5.9% (95% SK: 5.44, 6.41). Faktor yang berkaitan dengan  hipertensi yang lebih teruk 
dilihat di kalangan 30-39 tahun (Nisbah Odd = 1.68, 95% SK: 1.47, 1.93), 40-49 tahun 
(Nisbah Odd = 2.92, 95% SK : 2.53, 3.36), 50–59 tahun (Nisbah Odd = 4.67, 95% SK: 
3.97,5.49), 60 tahun ke atas (Nisbah Odd = 8.09, 95% SK: 6.71, 9.76), luar bandar (Nisbah 
Odd = 1.15, 95% SK: 1.02,1.28), lelaki (Nisbah Odd = 2.15, 95% SK: 1.95, 2.38), bangsa 
Melayu (Nisbah Odd = 1.23, 95% SK: 1.07, 1.41), mempunyai pendidikan tidak formal 
(Nisbah Odd = 1.73, 95% SK: 1.37, 2.20) pendidikan sekolah rendah (Nisbah Odd = 1.41, 
95% SK: 1.21, 1.64) (Nisbah Odd = 1.31, 95% SK: 1.12, 1.53), sudah berkahwin (Nisbah 
Odd = 0.86, 95% SK: 0.77, 0.98), perokok (Nisbah Odd = 0.84, 95% SK: 0.76, 0.94) 
(Nisbah Odd = 0.91, 95% SK: 0.83, 0.97), mempunyai diabetes mellitus (Nisbah Odd = 
1.24, 95% SK: 1.10, 1.39) berlebihan berat badan (Nisbah Odd =2.06, 95% SK: 1.88, 
2.26) dan obesiti (Nisbah Odd =4.58, 95% SK: 4.03, 5.21). 
Kesimpulan: Analisis regresi pelbagai ordinal sampel kompleks menunjukkan usia, 
lokasi tempat tinggal, jantina, etnik, status pendidikan, status pendapatan, status 
perkahwinan, Diabetes Mellitus dan berlebihan berat badan dikaitkan untuk mempunyai 
hipertensi yang lebih teruk.  
 
Kata kunci: Analisis data sekunder, Peringkat hipertensi, Kajian keratan rentas, Regresi 
Ordinal 
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FACTORS ASSOCIATED WITH HYPERTENSION STAGES AMONG 
MALAYSIAN ADULTS USING SECONDARY DATA FROM NATIONAL 
HEALTH AND MORBIDITY SURVEY 2015 
 
ABSTRACT 
 
Introduction: High blood pressure is a world’s classic problem and remains a major 
global health burden. Either singly or combined with other metabolic diseases, high blood 
pressure increased the risk of cardiovascular diseases. The epidemic was responsible for 
7.4 million deaths due to coronary heart disease, and 6.7 million deaths due to stroke.  
Objective: The objectives of this study was to determine the prevalence of hypertension 
by stages and factors associated with hypertension stages among the adult population in 
Malaysia. 
Methods: The study used secondary data from the nationwide cross-sectional population-
based survey using multistage stratified cluster sampling of the National Health and 
Morbidity Survey 2015. Socio-demographic factors, clinical parameters, behavioural 
characteristics and comorbidities risk factors were available for analysis. The average 
blood pressure reading was categorised to four groups according to The 7th Report of The 
Joint Committee on Prevention, Detection, Evaluation and Treatment of High Blood 
Pressure (JNC7) (normal, prehypertension, stage 1 hypertension and stage 2 
hypertension). Complex Sample Ordinal Logistic Regression was used for analysis. 
Results: A total of 15,738 adults were included in the study with the mean age of 41.10 
years (15.6 years). The prevalence of prehypertension, stage 1 hypertension and stage 2 
 xviii 
 
hypertension were 45.8% (95% CI: 44.66, 47.97), 15.1% (95% CI: 14.34, 15.92) and 5.9% 
(95% CI: 5.44, 6.41), respectively. Factors associated with more severe hypertension were 
observed among those in 30–39 years old (OR = 1.68, 95% CI: 1.47, 1.93), 40–49 years 
old (OR = 2.92, 95% CI: 2.53, 3.36), 50–59 years old (OR = 4.67, 95% CI: 3.97, 5.49), 
60 years old and above (OR = 8.09, 95% CI: 6.7, 9.76), rural residents (OR = 1.15, 95% 
CI: 1.02, 1.28), male (OR = 2.15, 95% CI: 1.95, 2.38), the Malays (OR = 1.23, 95% CI: 
1.07, 1.41), had non-formal education (OR = 1.73, 95% CI: 1.37, 2.20), had primary 
education (OR = 1.41, 95% CI: 1.21, 1.64), had low income (OR = 1.31, 95% CI: 1.12, 
1.53), married person (OR = 0.86, 95% CI: 0.77, 0.98), current smoker (OR = 0.84, 95% 
CI: 0.76, 0.94), were physically inactive (OR = 0.91, 95% CI: 0.83, 0.97), had Diabetes 
Mellitus (OR = 1.24, 95% CI: 1.10, 1.39), being overweight (OR = 2.06, 95% CI: 1.88, 
2.26) and being obese (OR = 4.58, 95% CI: 4.03, 5.21). 
Conclusion: Complex Sample Ordinal regression analysis revealed that age, locality, 
gender, ethnic, income, educational level, marital status, Diabetes Mellitus and BMI were 
the independent factors associated with severity of hypertension. 
 
Keywords: Secondary data analysis, Hypertension stages, Cross sectional, Ordinal 
Regression
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CHAPTER 1: INTRODUCTION 
1.1 Background 
High blood pressure is a world’s classic problem and remains a major global health 
burden. Either singly or combined with other metabolic diseases, such as diabetes and 
obesity, high blood pressure increased the risk of cardiovascular diseases such as stroke 
and ischemic heart diseases (Chobanian et al., 2003; Lozano et al., 2013). The past decade 
has seen the rapid development of high blood pressure research in many countries (WHO, 
2002; Lim et al., 2013). 
 
Approximately, 40% of adults aged 25 years and above in the world had been clinically 
diagnosed to have hypertension. An estimate of 17.5 million people died from 
cardiovascular diseases in a year, representing almost one-third of total deaths (WHO, 
2008). Meanwhile, published work of clustering cardiovascular burden of disease study 
in 21 regions highlighted that more than nine million of deaths were due to the 
complications of hypertension (Lim et al., 2013). This epidemic was also responsible for 
7.4 million deaths due to coronary heart disease and 6.7 million deaths because of stroke 
(WHO, 2011a; Lim et al., 2013). An excellent work from NCD Risk Factor Collaboration 
(NCD-RisC) on worldwide trends of raised blood pressure from 1975 to 2015 using 1479 
population-based study highlighted that numbers of adult with hypertension rose from 
594 million in 1975 to 1.13 billion people in 2015 (NCDRisC, 2017). According to WHO, 
by 2025, almost 1.56 billion (29.2%) people are projected to have hypertension (WHO, 
2002). 
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Hypertension especially uncontrolled and untreated hypertension is associated with 
increased risk of total and cardiovascular mortality among the general hypertensive 
population (Gu et al., 2010). Extensive research on the effect of potentially modifiable 
risk factors for myocardial infarction in large-scale data (52 countries) proved that those 
who have severe raised blood pressure increase the risk of having myocardial infarction 
by 2.5 times compared to those with normal blood pressure regardless of ethnic, sex and 
smoking status (Yusuf et al., 2004). Not only had those with clinical hypertension but it 
marked that individual in the prehypertension group is more likely to develop the 
cardiovascular disease by at least 1.5 times compared to those who were normal (Liszka 
et al., 2005; Qureshi et al., 2005; Wang et al., 2006). This evidence was earlier supported 
by a 34-years follow up of the Framingham Heart Study cohort indicating that the risk of 
congestive heart failure was more than two times higher for those who were in the higher 
quintile of blood pressure compared to the lower quintile during beginning of the study 
(Kannel and Belanger, 1991). 
 
Asia faces a large threat of an epidemic of hypertension specifically in the highly 
industrialised countries. In the year of 2000, over 180 million people in China were 
estimated to have hypertension and by the year 2025, it was estimated that this number 
will increase by about 100 million people from 2000 (Kearney et al., 2005), however, a 
recent study from NCD Risk Collaboration (2017) highlighted the current burden has 
already exceeded the projection. Approximately more than 40% of 1.13 billion adults with 
hypertension live in Asia in 2015, and 226 million alone of whom are in China (NCDRisC, 
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2017). In Malaysia, it was estimated nearly four million people in 2006 had clinical 
hypertension, and after almost 10 years the number rose to more than six million. Despite 
all the campaigns carried out and recommendations done, the number keeps rising and 
ironically, half of the population affected were not aware of their health condition (IPH, 
2008; IPH, 2011; MOH, 2014). A meta-analysis of one million adults from 61 prospective 
studies showed that if the disease is left uncontrolled and untreated, it will lead to one of 
its serious complication, such as ischemic heart disease, stroke, renal failure, blindness 
and myocardial infarction (Lewington S, 2002). 
 
A national representative survey involving more than 30,000 Malaysian adults in 2006 
indicated that only 68% of adults population were in healthy blood pressure group, 
however half of them were at risk of being hypertension (IPH, 2008). Recent evidence 
revealed that one out of three Malaysian adults were suffering from clinical hypertension 
and this trend has not changed for the past decade (IPH, 2008; IPH, 2011; IPH, 2015a). 
Existing research population based in Malaysia showed that hypertension was relatively 
higher in men, older age group and those with low household income (Rampal et al., 
2008). It was also found that there is a difference between factors associated with pre 
hypertension, stage 1 hypertension and stage 2 hypertension (Chiu et al., 2006; 
Gebreselassie and Padyab, 2015). 
 
Hypertension is a relatively high-cost disorder. The economic burden to the nation was 
well established and discussed (Bloom et al., 2011). According to Lyold et. al, the US 
government had spent more than 174 million dollars for this chronic disease (Lloyd-Jones 
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et al., 2010). As in Malaysia, Amrizal and colleagues highlighted the expenses of the 
government healthcare provider for managing hypertension patients admitted to 
government hospital almost Ringgit Malaysia 100 million in a year, and the cost for 
antihypertensive alone was more than Ringgit Malaysia 200 million (Amrizal et al., 
2005). Not only the expenses of healthcare increased for the country, it will definitely 
affect the  hypertensive individuals and their families in terms of lost productivity and 
reduced quality of life (Wang et al., 2006; WHO, 2011b). However, many complications 
of hypertension can be delayed or prevented by effective treatment and education. Strong 
evidence showed that reducing the blood pressure by lifestyle modification and a 
combination of drug therapy could lower the chance of having cardiovascular diseases 
(Mancia et al., 2007; WHO, 2011a; MOH, 2014; WHO, 2015). 
 
Based on the widely used Framingham study, normotensive blood pressure people had 
longer life expectancy by five years compared to people with hypertensive blood pressure 
(Franco et al., 2005). Previous research has established that patients with stage 2 
hypertension required greater reductions in blood pressure than patients in stage 1 in order 
to have a stable quality of life (Ueshima et al., 2000). In line with the finding, proven 
evidence by Ogden et al. that lowering blood pressure could reduce the stroke incidence 
by at least 25% and myocardial infarction by at least 20% (Ogden et al., 2000). 
 
Hypertension is a condition in which the blood vessels persistently raised pressure. 
According to The 7th Report of Joint Committee on Prevention, Detection, Evaluation 
and Treatment of High Blood Pressure (JNC7), a person with systolic blood pressure 
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(SBP) range 120—139 and/or diastolic blood pressure (DBP) range 80–89 is defined as 
having prehypertension, those with SBP range from 140–159 and/or DBP range 90–99 is 
defined as having stage 1 hypertension while those with SBP ≥ 160 and/or DBP ≥ 100 is 
defined as having stage 2 hypertension (Chobanian et al., 2003).  
 
1.2 Problem Statement 
In Malaysia, over the past decades, the prevalence of hypertension remained high and 
there is no significant improvement in the community despite all policies and 
hypertension task force that had been implemented by the government (IPH, 2008; IPH, 
2011; MOH, 2014). 
In addition, most of the previous studies were focused on hypertension among adults and 
its associated factors. But these did not give much clue regarding factors associated with 
the disease according to its severity and most importantly among the vulnerable 
prehypertensive group. Based on current knowledge, information on the severity of 
hypertension by stages and the factors associated with the severity has not well established 
in Malaysia. Although prehypertension has not yet considered a disease category, an early 
detection of it could prevent future risk of developing hypertension and other 
cardiovascular diseases by modification of lifestyle as suggested in JNC7 and Malaysian 
Clinical Hypertension (CPG) guideline (Chobanian et al., 2003; MOH, 2014).  
Moreover, previous evidences had highlights the importance of identifying the severity 
of hypertension. As for example, finding based on the widely used Framingham study 
showed normotensive blood pressure people had longer life expectancy by five years 
compared to people with hypertension stage 1 and hypertension stage 2 (Franco et al., 
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2005). In addition, according to Ueshima et al., patients with stage 2 hypertension 
required greater reductions in blood pressure than patients in stage 1 in order to have a 
stable quality of life (Ueshima et al., 2000). In line with other findings, proven evidence 
by Ogden et al. showed that lowering blood pressure could reduce the stroke incidence 
by at least 25% and myocardial infarction by at least 20% in those with stage 1 and stage 
2 hypertension (Ogden et al., 2000).  
According to Malaysia Clinical Guideline for Hypertension, 2014, a key component to 
ensure the blood pressure in the control level was tailored therapeutic regime according 
to the hypertension stages and their co-existing risk factors (MOH, 2014). 
1.3 Justification of the Study 
This study would provide the prevalence of hypertension by stages among adults. 
Presently, to current knowledge, there is no similar study done on the severity of 
hypertension in the local setting, thus this study produce the estimated population 
prevalence according to its severity group (pre-HPT, stage 1 HPT and stage 2 HPT). 
Moreover, there are significantly increasing numbers of those who have borderline 
hypertension (prehypertension) among adults worldwide. In line with the 6th global non 
communicable disease (NCD) target during the World Health Assembly 2013 that to 
reduce 25% of prevalence of raised blood pressure by 2025, a comprehensive, and 
consistent nationwide data is needed to understand the pattern of high blood pressure in 
Malaysia (WHO, 2013b). 
 
This study would also offer some important insights of the severity of hypertension in the 
local population. Quantifying the potential factors associated with different hypertension 
